These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20472416)

  • 41. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
    Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
    J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Irish injecting drug users and hepatitis C: the importance of the social context of injecting.
    Smyth BP; Barry J; Keenan E
    Int J Epidemiol; 2005 Feb; 34(1):166-72. PubMed ID: 15513970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users.
    Strathdee SA; Latka M; Campbell J; O'Driscoll PT; Golub ET; Kapadia F; Pollini RA; Garfein RS; Thomas DL; Hagan H;
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S304-12. PubMed ID: 15768339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis virus infection and liver disease in injecting drug users who died suddenly.
    McCruden EA; Hillan KJ; McKay IC; Cassidy MT; Clark JC
    J Clin Pathol; 1996 Jul; 49(7):552-5. PubMed ID: 8813952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
    Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis C virus infection and related risk factors among injection drug users in Montenegro.
    Baćak V; Laušević D; Mugoša B; Vratnica Z; Terzić N
    Eur Addict Res; 2013; 19(2):68-73. PubMed ID: 23006531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of injecting drug use status on hepatitis C-related referral and treatment.
    Stoové MA; Gifford SM; Dore GJ
    Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic review of HIV and HCV infection among drug users in China.
    Bao YP; Liu ZM
    Int J STD AIDS; 2009 Jun; 20(6):399-405. PubMed ID: 19451325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort: A retrospective longitudinal cohort study.
    McDonald SA; McAuley A; Hickman M; Bird SM; Weir A; Templeton K; Gunson R; Hutchinson SJ
    Int J Drug Policy; 2021 Oct; 96():103286. PubMed ID: 34011449
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment costs of hepatitis C infection among injection drug users in Canada, 2006-2026.
    Werb D; Wood E; Kerr T; Hershfield N; Palmer RW; Remis RS
    Int J Drug Policy; 2011 Jan; 22(1):70-6. PubMed ID: 21051212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
    Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
    Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HCV status knowledge and risk behaviours amongst intravenous drug users.
    Vidal-Trécan G; Coste J; Varescon-Pousson I; Christoforov B; Boissonnas A
    Eur J Epidemiol; 2000 May; 16(5):439-45. PubMed ID: 10997831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India.
    Solomon SS; Celentano DD; Srikrishnan AK; Vasudevan CK; Murugavel KG; Iqbal SH; Anand S; Kumar MS; Latkin C; Solomon S; Mehta SH
    Am J Epidemiol; 2010 Dec; 172(11):1259-67. PubMed ID: 20935070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.
    Dalgard O; Bjøro K; Hellum K; Myrvang B; Skaug K; Gutigard B; Bell H;
    Eur Addict Res; 2002 Jan; 8(1):45-9. PubMed ID: 11818693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
    Tsui JI; Evans JL; Lum PJ; Hahn JA; Page K
    JAMA Intern Med; 2014 Dec; 174(12):1974-81. PubMed ID: 25347412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
    Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
    CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. HCV dispersal patterns among intravenous drug users (IDUs) in Athens metropolitan area.
    Papachristou E; Tsagkovits A; Zavitsanou A; Hatzakis A; Paraskevis D
    Infect Genet Evol; 2016 Nov; 45():415-419. PubMed ID: 27721034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.